- Home
- ELDN vs ODC Comparison
ELDN vs ODC Comparison
Compare ELDN & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- ODC
- Stock Information
- Founded
- ELDN 2004
- ODC 1941
- Country
- ELDN United States
- ODC United States
- Employees
- ELDN N/A
- ODC N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- ODC Miscellaneous manufacturing industries
- Sector
- ELDN Health Care
- ODC Consumer Discretionary
- Exchange
- ELDN Nasdaq
- ODC Nasdaq
- Market Cap
- ELDN 288.5M
- ODC 305.8M
- IPO Year
- ELDN N/A
- ODC N/A
- Fundamental
- Price
- ELDN $4.29
- ODC $42.93
- Analyst Decision
- ELDN Strong Buy
- ODC
- Analyst Count
- ELDN 1
- ODC 0
- Target Price
- ELDN $16.00
- ODC N/A
- AVG Volume (30 Days)
- ELDN 232.7K
- ODC 23.8K
- Earning Date
- ELDN 03-27-2025
- ODC 03-11-2025
- Dividend Yield
- ELDN N/A
- ODC 2.15%
- EPS Growth
- ELDN N/A
- ODC 36.22
- EPS
- ELDN N/A
- ODC 3.09
- Revenue
- ELDN N/A
- ODC $454,094,000.00
- Revenue This Year
- ELDN N/A
- ODC N/A
- Revenue Next Year
- ELDN N/A
- ODC N/A
- P/E Ratio
- ELDN N/A
- ODC $13.81
- Revenue Growth
- ELDN N/A
- ODC 6.61
- 52 Week Low
- ELDN $1.52
- ODC $29.48
- 52 Week High
- ELDN $5.54
- ODC $46.50
- Technical
- Relative Strength Index (RSI)
- ELDN 44.28
- ODC 52.76
- Support Level
- ELDN $4.40
- ODC $41.37
- Resistance Level
- ELDN $4.65
- ODC $43.94
- Average True Range (ATR)
- ELDN 0.23
- ODC 0.81
- MACD
- ELDN -0.04
- ODC -0.04
- Stochastic Oscillator
- ELDN 8.16
- ODC 60.70
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.